BIOXALIS MEDICA

The company’s technology is based on the utilization of a hydrogel-based formulation to control sustained-release delivery properties of a drug or cosmeceutical product. It also engages in the research and development of products for use in the treatment of cancer. The company's efforts in oncology are focused on developing products for application as direct cancer treatment agents that have the dual objectives of extending life and improving the quality of life for cancer patients worldwide.